Men’ s Health: Natural health approaches for better prostate health
Astragalus radix extracts and Soybean extracts were combined into one 500 mg UMOOZE ® tablet and it is considered a food supplement. The objective of this study was to evaluate the benefits of UMOOZE ® as an add-on therapy for BPH by evaluating the improvements in symptoms of BPH, which were assessed according to the International Prostate Symptom Score( IPSS) and Quality of Life( QoL) index. The IPSS is a validated 7-item urinary symptoms severity scale.
Each subject received UMOOZE ® or a placebo. In this add-on study, the product was administered twice daily for 56 days. The benefits were evaluated at the baseline and subsequently on Day 28, Day 42 and Day 56, including the IPSS Index, QoL index, Qmax, PVR, prostate volume and Prostate-Specific antigen( PSA) test.
The study included the following inclusion criteria:
• Male – 40 years of age or older
• Screened by inquiry and diagnosed with BPH based on the result of a digital rectal examination( DRE) or transrectal ultrasonography( TRUS)
• Prostate volume ≥ 20 cm3
• Has complained of voiding symptoms related to BPH
• Has an IPSS ≥ 13 or a UFR measure of Qmax <= 15 ml / sec together with a voided volume ≥ 150 ml
• Serum PSA < 6.5 ng / ml
• Has been treated with medication for BPH
• Informed consent form signed
Men that were excluded from the study had the following criteria:
• Sensitivity to study product
• Had received prostatic surgery for BPH during the past 24 weeks
• Hard nodule found by DRE
• Ongoing neurogenic bladder, urinary tract infection, bladder stone, urethral stricture, bladder cancer, prostate cancer, severe liver dysfunction, severe renal dysfunction or severe cardiovascular disease
• Patient has clinically significant physical disability or abnormal findings in physical examination or laboratory testing judged by the investigator or co-investigator
• Participation in any clinical investigation during the last 30 days
• Individuals are judged by the investigators or co-investigator to be undesirable as subjects
43